Further evaluation of the Listeria vaccine in dogs with osteosarcoma
A study evaluating whether a new prescription diet will slow the progression of mitral valve disease in dogs
Assessing the Big Barker therapeutic mattress in dogs with osteoarthritis
A study of the cutaneous and rectal microbiome and the effect of cyclosporine therapy.
Transitional cell carcinoma (TCC) is the most common type of bladder cancer in dogs.
Assessing novel therapeutic that will be evaluated for its effect on the development and progression of osteoarthritis in dogs following CCL rupture and TPLO surgery
Evaluating a natural plant-derived supplement for dogs with arthritis
Evaluating an all-natural plant derived supplement for dogs with pruritus
We are testing a heparin derivative that is anti-inflammatory without being anticoagulant.
A Pilot Study to Evaluate an Intra-articular Injection for Dogs with Elbow Arthritis
This trial evaluates the safety and effectiveness of an antibody therapy designed to inhibit VEGF and delay or prevent spread of hemangioscarcoma after surgery
STUDY ON HOLD-A new plant-derived topical treatment to improve vision in dogs with cataract disease
A new study for dogs with arthritis of the knee.
Penn Vet is conducting a study to determine if near-infrared imaging can improve the surgeon’s ability to see cancer and cancer margins during surgery to remove feline soft tissue sarcomas.
Clinical trial evaluating surgery in combination with immunotherapy for cats with fibrosarcoma
Immune cells (known as T cells) are taken from the peripheral blood, stimulated, expanded and genetically modified in the laboratory to express a surface receptor that recognizes B cells
Determine whether a cell based vaccine can prevent the return of lymphoma after standard chemotherapy treatment.
A clinical trial evaluating the outcome of dogs with knee joint arthritis due to the rupture of the Cranial Cruciate Ligament in one knee joint, then stabilized with the Tibial Plateau Leveling Osteotomy (TPLO) procedure
We are currently enrolling dogs with signs of Canine Chronic Enteropathy, sometimes caused by Inflammatory Bowel Disease, in a clinical trial looking at the naturally occuring bacteria of the GI tract throughout treatment.
We propose to evaluate markers of inflammation, hemolysis, and endothelial activation in a randomized clinical trial in which dogs with primary immune-mediated hemolytic anemia and immune-mediated thrombocytopenia would receive fresh or old RBCs.
In this trial, we will be comparing I’m-Yunity’s® effect on survival time and quality of life to the standard chemotherapy treatment.